Proteonomix Inc
PROT
Morningstar Rating
Company Profile
Business Description
Proteonomix Inc develops pre-clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. The company focuses on developing therapeutics based upon the use of human cells and their derivative.
Contact
140 East Ridgewood Avenue, Suite 415
Paramus, NJ, 07652
Paramus, NJ, 07652
T +1 973 949-4195
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Jun 30, 2012
Fiscal Year End Dec 31, 2012
Stock Type Distressed
Employees 2